期刊文献+

卵巢癌抗原CA125 被引量:8

暂未订购
导出
摘要 CA125是1981年报告的一种新的卵巢癌抗原,与茁勒氏管分化有关,组织分布广泛,对妇科恶性肿瘤,尤其是对卵巢上皮性癌的特异性较高,可望用于卵巢癌的早期诊断。测定卵熊癌患者血清中的 CA125水平,可监测肿瘤的发展,判定术后化疗疗效,特别是当其水平再度升高时,可预测肿瘤复发和二次探查阳性。本文介绍了该抗原研究现状。
出处 《国外医学(妇产科学分册)》 1989年第5期260-263,共4页 Foreign Medical Sciences(Obstet Gynecol Fascicle)
  • 相关文献

同被引文献49

  • 1杨永彬,徐伟,陈建利,万小平.卵巢癌肿瘤标志物研究进展[J].国外医学(妇产科学分册),2004,31(4):229-232. 被引量:24
  • 2连利娟.卵巢肿瘤标志物及其对病情监测的意义[J].实用肿瘤杂志,1993,8(4):195-197. 被引量:9
  • 3李山,秦雪,何卫华.血清CA125在卵巢癌诊断中的价值及文献评价[J].中华检验医学杂志,2005,28(2):209-211. 被引量:37
  • 4Jemal A,Clegg LX,Ward E,et al.Annual report to the nation on the status of cancer,1975-2001,with a special feature regarding survival[J].Cancer,2004,101(1):3-27.
  • 5Altaras MM,Goldberg GL,Levin W,et al.What is a normal CA125 level ?[J].Gynecol Oncol,1995,56(3):475-476.
  • 6Bingle L,Singleton V,Bingle CD.The putative ovarian tumour marker gene HE4(WFDC2),is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms[J].Oncogene,2002,21(17):2768-2773.
  • 7Schummer M,Ng WV,Bumgarner RE,et al.Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.[J].Gene,1999,238(2):375-385.
  • 8Wang K,Gan L,Jeffrey E,et al.Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray[J].Gene,1999,229(1/2):101-108.
  • 9Drapkin R,von Horsten HH,Lin Y,et al.Human epididymis protein 4(HE4)is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas[J].Cancer Res,2005,65(6):2162-2169.
  • 10Hellstrom I,Raycraft J,Hayden-Ledbetter M,et al.The HE4(WFDC2)protein is a biomarker for ovarian carcinoma[J].Cancer Res,2003,63(13):3695-3700.

引证文献8

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部